Profile: Molecular Devices, now part of MDS Analytical Technologies, systems include multimode and dedicated benchtop readers, liquid handling instruments, systems for electrophysiology, high-content and live-cell imaging, cell-based screening, genomics, cellular neuroscience, label-free detection, laser capture microdissection and reagent assay kits for cell-based and biochemical assays. Our automated electrophysiology systems are used for primary and secondary screening and are capable of sophisticated research protocols as well. Our FlexStation 3 benchtop scanning microplate reader is flexible enough to be an assay development or screening tool for functional cellular assays, such a calcium mobilization or membrane potential. Utilizing multi-wavelength detection in conjunction with microplate-to-microplate transfer, real time kinetic traces can be analyzed to provide information rich data.

The company was founded in 1983, has revenues of USD 50-100 Million, has ~120 employees and is ISO 9001, CE certified. NASDAQ:MDCC (SEC Filings)